The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
Open accessAbstract
CConsensus from expert opinion and/or small clinical trials (including retrospective studies and case series).Scoring systems for making a comprehensive judgment on DAPT duration have been developed outside Japan.The PRECISE-DAPT score seeks to predict the bleeding risk during DAPT, and is calculated before PCI from age, history of bleeding, white blood cell count, hemoglobin, and creatinine clearance (Ccr).5 The DAPT score, the classical version prior to PRECISE-DAPT, is intended for use during the chronic phase of therapy at 1 year post-PCI and is increased with smoking, diabetes mellitus, prior myocardial infarction, prior PCI, paclitaxel-eluting stent implantation, stent diameter <3 mm, heart failure or left ventricular ejection fraction (LVEF) <30%, and vein graft stent, whereas higher age decreases the score.The DAPT score simultaneously estimates both bleeding and thrombotic risk.Studies have shown that, in patients with higher DAPT scores, continued use of DAPT reduced death and cardiovascular events, including myocardial infarction and stroke, without increasing bleeding events (Table 3).11,15,17 The DAPT score has also been reported to be applicable to Japanese patients.18 Of note, in the DAPT study that serves as the basis for calculating this score, patients who had bleeding events within the first year after PCI were excluded, and therefore this score is applicable only to low-risk patients who tolerated DAPT for 1 year after PCI.Prediction of risks for bleeding and thrombotic events immediately after PCI is more important than at ≥1 year after PCI, but enough evidence has not yet been obtained regarding this period.Therefore, care should be taken in applying those scoring systems developed outside Japan to Japanese clinical practice.In addition to the DAPT and PRECISE-DAPT scores, there are various bleeding risk scoring systems from the PARIS Registry, 19 ADAPT-DES study, 20 HORIZON AMI study, 21 CRUSADE study, 22 etc.The PARIS score derived from the PARIS Registry includes scores of not only bleeding risk but also thrombotic risk (Table 4).The common independent predictors of bleeding risk in those studies included chronic kidney disease (CKD), peripheral vascular disease, heart failure, and use of anticoagulants (or atrial fibrillation [AF]).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
Antman, E. M., Cohen, M., Bernink, P. J. L. M., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D., & Braunwald, E. (2000) · JAMA · doi:10.1001/jama.284.7.835 · Cited by 3,242
Cited by
Watanabe, H., Morimoto, T., Natsuaki, M., Yamamoto, K., Obayashi, Y., Ogita, M., Suwa, S., Isawa, T., Domei, T., Yamaji, K., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2021.5244 · Cited by 325
Self-citation
Metadata
- Authors
- Nakamura, M., Kimura, K., Kimura, T., Ishihara, M., Otsuka, F., Kozuma, K., Kosuge, M., Shinke, T., Nakagawa, Y., Natsuaki, M., Yasuda, S., Akasaka, T., Kohsaka, S., Haze, K., & Hirayama, A.
- Venue
- Circulation Journal
- Publisher
- Japanese Circulation Society
- Published
- 2020-04-24
- Volume
- 84
- Issue
- 5
- Pages
- 831-865
- ISSN
- 1346-9843 (ISSN-L)
- 1347-4820
- OpenAlex
- W3012340745
- Cited by
- 352
- References
- 179
- FWCI
- 27.93
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease. https://app.cochat.ai/papers/10.1253/circj.cj-19-1109
- The paper
- Nakamura, M., Kimura, K., Kimura, T., Ishihara, M., Otsuka, F., Kozuma, K., Kosuge, M., Shinke, T., Nakagawa, Y., Natsuaki, M., Yasuda, S., Akasaka, T., Kohsaka, S., Haze, K., & Hirayama, A. (2020). JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease. Circulation Journal. https://doi.org/10.1253/circj.cj-19-1109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.